Volume 30 - Issue 2

Review Article Biomedical Science and Research Biomedical Science and Research CC by Creative Commons, CC-BY

AI -A Novel Tool for Oral Cancer Diagnosis and Prevention: Current Applications and Future Perspectives

*Corresponding author:Shaista Suhail, Department of Microbiology, BBD College of Dental Sciences, BBD University, Lucknow, India.

Received:February 17, 2026; Published:February 24, 2026

DOI: 10.34297/AJBSR.2026.30.003903

Abstract

Oral cancer represents a major global health burden, particularly in developing countries, where delayed diagnosis and limited access to specialized healthcare services contribute to poor prognosis and high mortality rates [1,2]. Despite advancements in diagnostic modalities such as clinical examination, imaging, and histopathology, early detection of oral cancer remains a significant challenge. In recent years, Artificial Intelligence (AI) has emerged as a transformative technology in healthcare, offering innovative solutions for early diagnosis, risk prediction, and prevention of oral cancer [3-6]. AI-driven systems utilize machine learning and deep learning algorithms to analyze clinical images, radiographs, histopathological slides, and molecular datasets with high accuracy and reproducibility. This review provides a comprehensive overview of the role of AI in oral cancer diagnosis and prevention. Current applications of AI in clinical image analysis, radiographic interpretation, histopathological assessment, and biomarker-based detection are critically discussed [7-12]. Additionally, the contribution of AI to preventive strategies, including risk assessment, population-level screening, and patient education, is highlighted. The integration of AI into oral healthcare has the potential to improve early detection, reduce diagnostic variability, and enhance accessibility, particularly in resource-limited settings [13]. However, challenges related to data quality, ethical concerns, algorithm transparency, and clinical validation remain barriers to widespread implementation [14-18]. This review also explores future research directions and technological advancements required for the successful translation of AI into routine oral oncology practice.

Keywords: Artificial intelligence, Oral cancer, Early detection, Prevention, Machine learning, Deep learning

Introduction

Oral cancer, predominantly Oral Squamous Cell Carcinoma (OSCC), accounts for a substantial proportion of cancer-related morbidity and mortality worldwide [1]. The burden of oral cancer is particularly high in South and Southeast Asia, including India, due to widespread tobacco use, alcohol consumption, and betel quid chewing [2,19]. Diagnosis of cancer can be divided into three categories: predicting the risk of occurrence of the disease, prediction of its recurrence and finally predicting the chances of survival of the cancer patients. Detection of cancers is most commonly done via medical imaging and histological methods. The World Health Organization (WHO), in their 2022 report, identified cancer as one of the leading causes of death, accounting for about 16% of deaths worldwide. The Cancer-Moon shot community aims to reduce the cancer death rate by half in the next 25 years and wants to improve the lives of cancer-affected people. Cancer mortality can be reduced if detected early and treated appropriately.

A major concern in oral oncology is that a significant number of cases are diagnosed at advanced stages, resulting in poor survival outcomes, aggressive treatment modalities, and reduced quality of life. Early detection of oral cancer significantly improves prognosis and treatment outcomes [20]. However, conventional diagnostic approaches such as visual inspection, palpation, and histopathological examination are often limited by subjectivity, inter-observer variability, and dependence on clinical expertise [21]. Furthermore, access to specialized diagnostic facilities remains inadequate in rural and underserved regions. These limitations emphasize the need for innovative, objective, and scalable diagnostic tools.

Artificial Intelligence (AI) has emerged as a promising adjunct in modern healthcare. AI refers to computational systems capable of simulating human intelligence, including learning, reasoning, and pattern recognition [22]. In dentistry and oral oncology, AI has demonstrated remarkable potential in assisting clinicians by enabling accurate lesion detection, risk stratification, and evidence-based decision-making [13]. The integration of AI into oral healthcare systems holds promise for transforming traditional diagnostic paradigms and improving patient outcomes.

Artificial Intelligence in Healthcare: An Overview

AI in healthcare is primarily driven by Machine Learning (ML) and Deep Learning (DL) techniques [3]. Machine learning involves algorithms that learn from structured data to identify patterns and make predictions, whereas deep learning employs artificial neural networks with multiple layers to analyze complex datasets [23]. Convolutional Neural Networks (CNNs), a subtype of deep learning, are particularly effective in image-based analysis and have revolutionized medical imaging and digital pathology [24]. AI systems are trained using large datasets comprising clinical records, imaging data, histopathological slides, and molecular profiles. These systems can process vast volumes of data rapidly and consistently, enabling detection of subtle pathological patterns that may be overlooked by human observers [5,6]. Successful AI applications have been reported across radiology, pathology, dermatology, and oncology, supporting early diagnosis and clinical decision-making [25,26]. In oral healthcare, AI models are increasingly applied to intraoral photographs, panoramic radiographs, CBCT scans, and digitized biopsy slides. The integration of multimodal data enables comprehensive diagnostic assessment, positioning AI as a powerful tool in oral cancer care

Applications of Artificial Intelligence in Oral Cancer Diagnosis

Clinical Image-Based Detection

Clinical examination is the first step in oral cancer screening; however, early lesions are often subtle and asymptomatic. AIpowered image analysis systems have demonstrated high accuracy in evaluating intraoral photographs and identifying potentially malignant oral disorders such as leukoplakia, erythroplakia, oral lichen planus, and oral submucous fibrosis [7,9]. Deep learning models trained on large image datasets can differentiate normal oral mucosa from suspicious lesions with high sensitivity and specificity [10,11]. These systems are particularly valuable in mass screening programs and tele-dentistry platforms, enabling remote assessment and early referral. AI-assisted image analysis significantly enhances screening efficiency, especially in community-based and rural healthcare settings.

Radiographic Interpretation

Radiographic imaging plays a vital role in evaluating tumor extent, bone invasion, and disease progression. Interpretation of panoramic radiographs and CBCT scans is often subjective and dependent on clinician experience. AI-based radiographic analysis systems can automatically detect pathological changes, evaluate osseous involvement, and assist in treatment planning [25,27]. Automated analysis reduces observer bias and improves diagnostic reproducibility. AI algorithms can extract quantitative features from radio-graphs, supporting early detection of malignant changes and enhancing clinical decision-making.

Histopathological Evaluation

Histopathological examination remains the gold standard for definitive diagnosis of oral cancer. However, interpretation of biopsy specimens is time-consuming and subject to inter- and intra-observer variability. AI-assisted digital pathology systems have been developed to analyze digitized histopathological slides and identify dysplasia, tumor grading, and margin status [8,12]. Machine learning and deep learning models support pathologists by highlighting areas of concern, quantifying histological features, and improving diagnostic consistency. Such systems have the potential to reduce diagnostic errors and standardize reporting in oral pathology.

Molecular and Biomarker Analysis

Recent advances have focused on salivary and molecular biomarkers for early oral cancer detection. AI- driven analytics have been applied to genomic, proteomic, and metabolomic datasets to identify complex biomarker patterns associated with malignant transformation [28-30]. Saliva-based diagnostics combined with AI offer a non-invasive, cost-effective approach for early screening and monitoring of high-risk individuals. These approaches align well with population-level preventive strategies (Table 1).

Role of Artificial Intelligence in Oral Cancer Prevention

AI plays an essential role in preventive oral oncology by enabling personalized risk assessment, population screening, and patient education. Predictive models integrate behavioral, genetic, and environmental risk factors to estimate an individual’s likelihood of developing oral cancer [13]. AI-powered mobile screening tools and telemedicine platforms support large-scale community screening programs, particularly in underserved areas [9]. These technologies reduce diagnostic delays and improve referral pathways. Furthermore, AI-driven educational platforms and chatbots provide personalized counseling and behavioral interventions aimed at reducing tobacco and alcohol use, thereby strengthening preventive efforts (Figure 1).

Biomedical Science &, Research

Table 1:Applications of AI in Oral Cancer Diagnosis.

Biomedical Science &, Research

Figure 1:

Oral Cancer

As per the statistics of WHO, 2020, oral cancer constitutes around 2–4% of all cancers globally, with a higher burden in South and Southeast Asia. The oral cavity includes the lips, buccal mucosa, tongue, floor of the mouth, hard palate, and gingiva, and is responsible for functions such as speech, mastication, and swallowing. Oral cancer mainly arises from the mucosal lining of the oral cavity, where the epithelial cells are frequently exposed to carcinogens like tobacco, alcohol, and betel nut. Oral cancer usually begins as a small lesion in the mucosa, often presenting as leukoplakia, erythroplakia, or a non-healing ulcer in the early stage, and when diagnosed early it is largely treatable. As the disease progresses, the tumor invades deeper connective tissues, muscles, and adjacent structures, making treatment more difficult in advanced stages. If left untreated, it can spread to regional lymph nodes and distant organs. Recurrence is also possible even after adequate therapy, hence regular follow-up and early diagnosis are essential. Depending on the type of cells involved, oral cancers are classified as squamous cell carcinoma (most common), verrucous carcinoma, and minor salivary gland carcinomas. Based on the extent of invasion, they are categorized as in situ, locally invasive, and metastatic oral cancers. The diagnostic techniques commonly used to detect oral cancer include clinical examination, biopsy, CT, MRI, and adjunctive imaging methods. Clinical diagnosis can be challenging due to variability in lesion appearance and similarity to benign conditions. Recently, Artificial Intelligence (AI) has emerged as a supportive tool in oral cancer detection. AI systems analyze clinical images, radiographs, and histopathological slides to assist in early detection and classification. However, challenges remain due to variations in lesion size, shape, color, and image quality, as well as differences in patient populations. Despite these challenges, AI shows promising potential in improving early diagnosis and prognosis of oral cancer (Figures 2,3).

Biomedical Science &, Research

Figure 2:

Biomedical Science &, Research

Figure 3:

Advantages of Artificial Intelligence in Oral Oncology

The incorporation of AI into oral cancer care offers several advantages, including improved early detection, reduced diagnostic variability, rapid processing of large datasets, enhanced accessibility in low-resource settings, and support for personalized preventive strategies [6,13].

Challenges and Ethical Considerations

Despite its promising potential, AI implementation faces challenges related to data quality, lack of standardized datasets, and limited external validation [14]. Ethical concerns regarding patient privacy, informed consent, and algorithmic bias must be addressed to ensure responsible use [17,18]. Importantly, AI should function as a supportive tool rather than a replacement for clinical judgment. Robust regulatory frameworks and clinician training are essential for successful adoption

Future Scope and Research Directions

Future advancements in AI are expected to focus on realtime diagnostic tools integrated into routine dental practice. AI-enabled chairside screening devices and smartphone-based diagnostic applications may significantly enhance early detection and accessibility [13,15]. Multicenter prospective clinical trials are required to validate AI models across diverse populations. The development of explainable AI systems will improve transparency and clinician trust. Integration of AI with electronic health records, wearable devices, genomics, and salivary diagnostics is expected to advance precision oral oncology over the next decade [31-35].

Discussion

Cancer continues to be a significant global health challenge, with early diagnosis, accurate prognosis, and personalized treatment being critical for improving patient outcomes. Cancer ranks as the primary killer in both developed and developing countries and the death toll due to oncological diseases is expected to rise to 13.1 million by 2024. Delay in its detection often leads to poor prognosis and lowers the chances of survival. However, early detection of cancers can diminish its mortality rates. In recent years, the application of Artificial Intelligence (AI) has emerged as a promising approach to revolutionize cancer care, offering unprecedented opportunities for advancements in cancer research and clinical practice. Machine learning, a subfield of AI, has been extensively applied in cancer research because of its ability to analyze complex data patterns and make accurate predictions. Several studies have reviewed the application of machine learning in cancer research, providing valuable insights into its potential and limitations.

Artificial Intelligence (AI) is revolutionizing early cancer detection, with Machine Learning (ML) and Deep Learning (DL) at the forefront. While ML requires human guidance, DL autonomously learns from data using neural networks, excelling in image and speech recognition, pattern detection, and natural language processing, making it highly valuable in oncology. AI offers many tools and platforms to facilitate more understanding and tackling of this life-threatening disease. AI-based systems can help pathologists in diagnosing cancer more accurately and consistently, reducing the case error rates. Predictive-AI models can estimate the likelihood for a person to get cancer by identifying the risk factors. Big data, together with AI, can enable medical experts to develop customized treatments for cancer patients. The side effects from this kind of customized therapy will be less severe in comparison with the generalized therapies. However, many of these AI tools will remain ineffective in fighting against cancer and saving the lives of millions of patients unless they are accessible and understandable to biologists, oncologists, and other medical cancer researchers. The aim is to presents the trends, challenges, and future directions of AI in cancer research. Artificial Intelligence represents a transformative advancement in the diagnosis and prevention of oral cancer. By enabling early detection, accurate diagnosis, and personalized preventive strategies, AI has the potential to significantly improve patient outcomes. With continued research, ethical implementation, and clinical validation, AI is poised to become an integral component of future oral cancer care.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6): 394-424.
  2. Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4-5): 309-316.
  3. LeCun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521(7553): 436-444.
  4. Esteva A, Kuprel B, Novoa RA, Justin Ko, Susan M Swetter, et al. (2017) Dermatologist-level classification of skin cancer with deep neural networks. Nature 542(7639): 115-118.
  5. Obermeyer Z, Emanuel EJ (2016) Predicting the future-big data, machine learning, and clinical medicine. N Engl J Med 375(13): 1216-1219.
  6. Topol EJ (2019) High-performance medicine: the convergence of human and artificial intelligence. Nat Med 25(1): 44-56.
  7. Jeyaraj PR, Samuel Nadar ER (2019) Computer-assisted medical image classification for early diagnosis of oral cancer employing deep learning algorithm. J Cancer Res Clin Oncol 145(4): 829-837.
  8. Halicek M, Little JV, Wang X, Mihir Patel, Christopher C Griffith, et al. (2016) Tumor margin classification of head and neck cancer using hyperspectral imaging and convolutional neural networks. Proc SPIE Int Soc Opt Eng 9791: 97910C.
  9. Sunny S, Baby A, James BL, Dev Balaji, Aparna N V, et al. (2019) A smart tele-cytology point-of-care platform for oral cancer screening. PLoS One 14(11): e0224885.
  10. Aubreville M, Knipfer C, Oetter N, et al. (2017) Automatic classification of cancerous tissue in laser endomicroscopy images of the oral cavity using deep learning. Sci Rep 7(1): 11979.
  11. Kumar M, Prasad K, Ramachandraiah R (2020) Oral cancer detection using deep learning techniques. J Med Syst 44(2): 34.
  12. Pentapati KC, Smriti K, Gadicherla S, Choudhury N (2021) Artificial intelligence in oral cancer diagnosis and prognosis: A systematic review. J Oral Maxillofac Pathol 25(3): 476-482.
  13. Patil S, Majumdar B, Sarode GS, et al. (2020) Artificial intelligence and oral cancer: Future prospects. Oral Oncol 104: 104598.
  14. Kelly CJ, Karthikesalingam A, Suleyman M, Greg Corrado, Dominic King, et al. (2019) Key challenges for delivering clinical impact with artificial intelligence. BMC Med 17: 195.
  15. Yu KH, Beam AL, Kohane IS (2018) Artificial intelligence in healthcare. Nat Biomed Eng 2(10): 719-731.
  16. He J, Baxter SL, Xu J, Jiming Xu, Xingtao Zhou, et al. (2019) The practical implementation of artificial intelligence technologies in medicine. Nat Med 25(1): 30-36.
  17. Vokinger KN, Feuerriegel S, Kesselheim AS (2021) Mitigating bias in machine learning. N Engl J Med 384(16): 1481-1484.
  18. Char DS, Shah NH, Magnus D (2018) Implementing machine learning in health care. N Engl J Med 378(11): 981-983.
  19. Gupta B, Johnson NW (2014) Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One 9(11): e113385.
  20. Sankaranarayanan R, Ramadas K, Thomas G, Richard Muwonge, Somanathan Thara, et al. (2005) Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 365(9475): 1927-1933.
  21. Lingen MW, Abt E, Agrawal N, Anil K Chaturvedi, Ezra Cohen, et al. (2017) Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders. J Am Dent Assoc 148(10): 712-727.
  22. McCarthy J (2007) What is artificial intelligence? AI Magazine 28(4): 123.
  23. Shrestha A, Mahmood A (2019) Review of deep learning algorithms and architectures. IEEE Access 7: 53040-53065.
  24. Litjens G, Kooi T, Bejnordi BE, Arnaud Arindra Adiyoso Setio, Francesco Ciompi, et al. (2017) A survey on deep learning in medical image analysis. Med Image Anal 42: 60-88.
  25. Rajpurkar P, Irvin J, Ball RL, et al. (2018) Deep learning for chest radiograph diagnosis. NPJ Digit Med 1: 18.
  26. Erickson BJ, Korfiatis P, Akkus Z, Kline TL (2017) Machine learning for medical imaging. Radiographics 37(2): 505-515.
  27. Poedjiastoeti W, Suebnukarn S (2018) Application of convolutional neural network in the diagnosis of jaw tumors. Healthcare (Basel) 6(3): 106.
  28. Abedi E, Seguin C, Li H, (2020) Saliva-based oral cancer detection using machine learning. Sci Rep 10: 7829.
  29. Kaur J, Matta A, Kak I, Gunjan Srivastava, Jasmeet Assi, et al. (2014) S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer 134(6): 1379-1388.
  30. Punyani SR, Sathawane RS (2013) Salivary biomarkers for oral cancer detection. J Oral Maxillofac Pathol 17(3): 369-374.
  31. Karhade AV, Bongers MER, Groot OQ, et al. (2019) Artificial intelligence in orthopaedics. Bone Joint J 101-B (12): 1479-1487.
  32. Shortliffe EH, Sepúlveda MJ (2018) Clinical decision support in the era of artificial intelligence. JAMA 320(21): 2199-2200.
  33. Ramesh AN, Kambhampati C, Monson JRT, Drew PJ (2004) Artificial intelligence in medicine. Ann R Coll Surg Engl 86(5): 334-338.
  34. Choi RY, Coyner AS, Kalpathy Cramer J, Michael F Chiang, J Peter Campbell (2020) Introduction to machine learning. Radiographics 40(3): 683-695.
  35. Obermeyer Z, Lee TH (2017) Lost in thought-the limits of the human mind and the future of medicine. N Engl J Med 377(13): 1209-1211.

Sign up for Newsletter

Sign up for our newsletter to receive the latest updates. We respect your privacy and will never share your email address with anyone else.